Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program
Standard
Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. / El Fakih, Riad; Greinix, Hildegard; Koh, Mickey; Shaw, Bronwen; Mohty, Mohamad; Al Nahedh, Mohammad; Saber, Wael; Kharfan-Dabaja, Mohamed A; Perales, Miguel-Angel; Savani, Bipin N; Majhail, Navneet S; Passweg, Jakob R; Sureda, Anna; Ahmed, Syed Osman; Gluckman, Eliane; Riches, Marcie; El-Jawahri, Areej; Rondelli, Damiano; Srivastava, Alok; Faulkner, Lawrence; Atsuta, Yoshiko; Ballen, Karen K; Rasheed, Walid; Okamoto, Shinichiro; Seber, Adriana; Chao, Nelson; Kröger, Nicolaus; Kodera, Yoshihisa; Szer, Jeff; Hashmi, Shahrukh K; Horowitz, Mary M; Weisdorf, Daniel; Niederwieser, Dietger; Aljurf, Mahmoud.
In: TRANSPL CELL THER, Vol. 27, No. 3, 03.2021, p. 267.e1-267.e5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program
AU - El Fakih, Riad
AU - Greinix, Hildegard
AU - Koh, Mickey
AU - Shaw, Bronwen
AU - Mohty, Mohamad
AU - Al Nahedh, Mohammad
AU - Saber, Wael
AU - Kharfan-Dabaja, Mohamed A
AU - Perales, Miguel-Angel
AU - Savani, Bipin N
AU - Majhail, Navneet S
AU - Passweg, Jakob R
AU - Sureda, Anna
AU - Ahmed, Syed Osman
AU - Gluckman, Eliane
AU - Riches, Marcie
AU - El-Jawahri, Areej
AU - Rondelli, Damiano
AU - Srivastava, Alok
AU - Faulkner, Lawrence
AU - Atsuta, Yoshiko
AU - Ballen, Karen K
AU - Rasheed, Walid
AU - Okamoto, Shinichiro
AU - Seber, Adriana
AU - Chao, Nelson
AU - Kröger, Nicolaus
AU - Kodera, Yoshihisa
AU - Szer, Jeff
AU - Hashmi, Shahrukh K
AU - Horowitz, Mary M
AU - Weisdorf, Daniel
AU - Niederwieser, Dietger
AU - Aljurf, Mahmoud
N1 - Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - Establishing a hematopoietic cell transplantation (HCT) program is complex. Planning is essential while establishing such a program to overcome the expected challenges. Authorities involved in HCT program establishment will need to coordinate the efforts between the different departments required to start up the program. One essential department is pharmacy and the medications required. To help facilitate this, the Worldwide Network for Blood and Marrow Transplantation organized a structured survey to address the essential medications required to start up an HCT program. A group of senior physicians and pharmacists prepared a list of the medications used at the different phases of transplantation. These drugs were then rated by a questionnaire using a scale of necessity based on the stage of development of the transplant program. The questionnaire was sent to 30 physicians, in different parts of the world, who have between 5 and 40 years of experience in autologous and/or allogeneic transplantation. This group of experts scored each medication on a 7-point scale, ranging from an absolute requirement (score of 1) to not required (score of 7). The results are presented here to help guide the prioritization of required medications.
AB - Establishing a hematopoietic cell transplantation (HCT) program is complex. Planning is essential while establishing such a program to overcome the expected challenges. Authorities involved in HCT program establishment will need to coordinate the efforts between the different departments required to start up the program. One essential department is pharmacy and the medications required. To help facilitate this, the Worldwide Network for Blood and Marrow Transplantation organized a structured survey to address the essential medications required to start up an HCT program. A group of senior physicians and pharmacists prepared a list of the medications used at the different phases of transplantation. These drugs were then rated by a questionnaire using a scale of necessity based on the stage of development of the transplant program. The questionnaire was sent to 30 physicians, in different parts of the world, who have between 5 and 40 years of experience in autologous and/or allogeneic transplantation. This group of experts scored each medication on a 7-point scale, ranging from an absolute requirement (score of 1) to not required (score of 7). The results are presented here to help guide the prioritization of required medications.
KW - Bone Marrow
KW - Bone Marrow Transplantation
KW - Hematopoietic Stem Cell Transplantation
KW - Transplantation, Homologous
U2 - 10.1016/j.jtct.2020.12.015
DO - 10.1016/j.jtct.2020.12.015
M3 - SCORING: Journal article
C2 - 33781535
VL - 27
SP - 267.e1-267.e5
JO - TRANSPL CELL THER
JF - TRANSPL CELL THER
SN - 2666-6375
IS - 3
ER -